Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). [electronic resource]
Producer: 20021023Description: 585-90 p. digitalISSN:- 0002-9149
- Administration, Oral
- Aged
- Blood Vessel Prosthesis Implantation
- Coronary Artery Disease -- complications
- Diabetes Complications
- Diabetes Mellitus -- mortality
- Endpoint Determination
- Eptifibatide
- Female
- Follow-Up Studies
- Humans
- Hypoglycemic Agents -- therapeutic use
- Incidence
- Insulin -- therapeutic use
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Peptides -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- therapeutic use
- Stents
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Evaluation Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.